Financial Data and Key Metrics Changes - Q1 sales were approximately $250 million, which was below the forecast of $258 million to $260 million, representing a year-over-year decline largely due to supply chain issues in eye care [6][12] - Gross margin expanded by 150 basis points to 56.2%, attributed to ongoing cost savings efforts [8][12] - Diluted EPS was $0.95, up approximately 6% compared to the adjusted prior year, despite the sales miss [9][16] - Free cash flow reached a quarterly record of $78 million, enabling capital deployment to enhance shareholder value [9][17] Business Line Data and Key Metrics Changes - North America segment revenues decreased by 8.4%, while International segment revenues increased by 7.1% year-over-year [13] - The International segment experienced organic sales growth of 7%, driven by broad-based sales growth [14] Market Data and Key Metrics Changes - The company anticipates a full-year revenue of $1.1 billion to $1.115 billion, with organic revenue expected to decline approximately 1.5% to 3% [22] - For Q2, revenues are expected to be approximately $256 million to $259 million, down year-over-year due to supply chain timing and lower retail order patterns [22] Company Strategy and Development Direction - The company announced the acquisition of Pillar Five to secure and expand long-term supply for eye care products, which is expected to improve supply stability in the second half of the year [11][19] - The company maintains confidence in its diverse consumer healthcare portfolio and long-term growth opportunities despite the disappointing start to the year [21] Management Comments on Operating Environment and Future Outlook - Management highlighted heightened business environment uncertainty due to supply chain constraints, high inflation, and geopolitical events [5] - The company expects significant improvement in Clear Eye shipments in the second half of the year, with a focus on recovering lost sales in FY 2027 and beyond [22][29] Other Important Information - The anticipated cost of tariffs for the full year is approximately $5 million, which the company expects to offset through strategic actions [15] - The acquisition of Pillar Five is expected to be funded from cash on hand and will have a minimal impact on the P&L, being approximately neutral to EPS on a normalized basis [19][63] Q&A Session Summary Question: Change in retail order patterns and inventory destocking - Management noted increased order volatility from retailers in July, which is expected to significantly impact Q2 but anticipates a return to normalized order trends in the second half [25][26] Question: Confidence in Clear Eyes supply normalizing - Management expressed confidence in supply normalizing in the back half of the year, with expectations of recovering lost sales in FY 2027 and beyond [29][30] Question: Impact of bringing eye care manufacturing in-house on margins - Management does not expect any meaningful movement in gross margin as a result of the acquisition of Pillar Five, indicating it will be largely neutral to the P&L [37][38] Question: Inventory levels and destocking expectations - Management does not see any meaningful ramp-up of inventory among their largest customers, indicating that inventory levels are not inflated [45][46] Question: Performance of the women's health business - Management remains optimistic about the continued recovery of the Summer's Eve brand, expecting positive performance for the remainder of the year [48] Question: Sustaining international growth - Management is confident in sustaining international growth, expecting a slight softening compared to the first quarter but still in line with long-term growth algorithms [70]

Financial Data and Key Metrics Changes - The company achieved a record performance in Q2 2025 with a 35% year-over-year revenue growth, reaching $234.5 million, and a 70% increase in consolidated adjusted EBITDA to $39.6 million, representing a 16.9% margin [7][20] - Year-to-date revenues increased by 25.5% to $412.4 million, with year-to-date consolidated adjusted EBITDA rising 46% to $58.6 million, or 14.2% of revenue [20][21] - The company reported positive GAAP net income of $18.4 million, or $0.42 per diluted share, compared to a net loss of $10.2 million in the prior year [21][22] Business Line Data and Key Metrics Changes - In the Assessment, Permitting and Response segment, Q2 revenue nearly doubled to $103.9 million, with adjusted EBITDA of $27.6 million, or 26.5% of revenue [23] - The Measurement and Analysis segment saw a revenue increase of nearly 15% to $62.8 million, with adjusted EBITDA rising to $18.3 million, or 29.1% of revenue [24][25] - The Remediation and Reuse segment's revenue increased to $67.8 million, with adjusted EBITDA growing to $10 million and a margin of 14.8% [26] Market Data and Key Metrics Changes - 80% of 2024 revenue was generated from U.S. clients, primarily in the private sector, indicating strong demand across various industries [13] - The company noted increased regulatory influence from local and state governments in the U.S., which is expected to drive continued demand for its services [14][15] Company Strategy and Development Direction - The company is focused on driving strong organic growth, generating solid cash flow, and simplifying its balance sheet, with a long-term organic revenue growth expectation of 7% to 9% annually [11][12] - The strategic priorities include capital allocation to high-return opportunities, emphasizing scalable profitability, and increasing operating and free cash flow generation [17][19] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about current and future business prospects, citing ongoing client demand for environmental science-based solutions [17] - The company anticipates minimal impact from regulatory uncertainties related to greenhouse gas regulations, as most clients operate in states with active regulations [15][16] Other Important Information - The company completed the redemption of remaining preferred shares, bringing leverage below three times pro forma [11] - The company raised its guidance for 2025, expecting revenue to surpass 2024 by 17% and adjusted EBITDA to grow 19% [12] Q&A Session Summary Question: Margins across business lines - Management indicated that margins in the Measurement and Analysis segment are expected to remain in the 18% to 22% range long-term, despite current strong performance due to operating leverage and project mix shifts [30][31] Question: Emergency response business outlook - Management noted that emergency response work is seen as an upside opportunity, with core business growth continuing independently [45][46] Question: Customer concerns - Management acknowledged that customers are dealing with macroeconomic factors but noted that planning cycles remain stable, sustaining demand for services [59][60] Question: Acquisition strategy - Management confirmed that while acquisitions are currently paused, there is a robust opportunity for future consolidation in the market [62][63] Question: PFAS activity and treatment - Management expressed optimism about the PFAS treatment business, noting regulatory developments and a growing patent portfolio that expands service offerings [39][94] Question: Organic growth drivers - Management attributed organic growth to deepening relationships with existing clients and regulatory shifts, rather than acquiring new clients [100][101]

Financial Data and Key Metrics Changes - Q1 sales were approximately $250 million, which was below the forecast of $258 million to $260 million, representing a year-over-year decline largely due to supply chain issues and lower sales in eye care [5][10] - Gross margin expanded by 150 basis points to 56.2%, attributed to cost savings efforts [6][12] - Diluted EPS was $0.95, up approximately 6% from the adjusted prior year, despite the sales miss [7][14] - Free cash flow reached a record $78 million, enabling capital deployment for shareholder value enhancement [7][15] Business Line Data and Key Metrics Changes - North America segment revenues decreased by 8.4%, while International segment revenues increased by 7.1% year-over-year [11][12] - The eye care segment faced significant supply constraints, impacting sales, while other segments like Dramamine and Fleet showed healthy consumption trends [6][12] Market Data and Key Metrics Changes - The International segment experienced organic sales growth of 7%, driven by broad-based sales growth [12] - E-commerce channel saw double-digit year-over-year consumption growth, indicating a long-term trend towards higher online purchasing [12] Company Strategy and Development Direction - The company announced the acquisition of Pillar Five to secure and expand long-term supply for eye care products, which is expected to improve supply stability in the second half of the year [9][17] - The company anticipates revenues for fiscal 2026 to be between $1.1 billion and $1.115 billion, with organic revenue expected to decline approximately 1.5% to 3% [20] Management's Comments on Operating Environment and Future Outlook - Management expressed disappointment in the start of the year but remains confident in the long-term growth opportunities of their consumer healthcare portfolio [19] - The company expects significant improvement in Clear Eye shipments in the second half of the year, despite current supply chain challenges [20][29] Other Important Information - The company maintained a leverage ratio of approximately 2.4 times and repurchased over 400,000 shares in Q1 [7][15] - The anticipated cost of tariffs for the full year is approximately $5 million, which the company expects to offset through strategic actions [13] Q&A Session Summary Question: Change in retail order patterns and inventory destocking - Management noted increased order volatility from retailers in July, disconnected from consistent consumption levels, impacting Q2 significantly [23][24] Question: Confidence in supply normalizing for Clear Eyes - Management expressed confidence in supply normalizing in the back half of the year, with new suppliers and a high-speed line expected to contribute [26][29] Question: Impact of bringing eye care manufacturing in-house on margins - Management indicated no meaningful movement in gross margin as a result of bringing manufacturing in-house, expecting it to be largely neutral to the P&L [36][39] Question: Outlook for cough and cold season - Management maintained the initial guidance for a modest decline in the cough and cold category, too early to tell at this point [42] Question: Inventory levels within segments - Management reported no meaningful ramp-up of inventory, indicating that current order patterns are disconnected from consumption [44] Question: Performance of Summer's Eve brand - Management expressed confidence in the continued positive momentum of the Summer's Eve brand for the remainder of the year [46] Question: International segment growth sustainability - Management expects to sustain international growth, projecting a long-term algorithm of over 5% for the segment [68]

Financial Data and Key Metrics Changes - CRH reported total revenues of $10.2 billion for Q2 2025, a 6% increase compared to the prior year, driven by favorable underlying demand and strong contributions from acquisitions [9][10] - Adjusted EBITDA for the quarter was $2.5 billion, reflecting a 9% increase year-over-year, with a margin expansion of 70 basis points [10][19] - The company raised its full-year adjusted EBITDA guidance to between $7.5 billion and $7.7 billion, indicating a 10% growth at the midpoint [9][33] Business Line Data and Key Metrics Changes - Americas Materials Solutions saw a 24% increase in total revenues and adjusted EBITDA compared to the prior year, despite adverse weather conditions [11] - Essential Materials reported a 4% increase in revenues, supported by increased volumes and positive pricing momentum in Aggregates and Cement [11] - International Solutions experienced a 13% increase in revenue and a 23% increase in adjusted EBITDA, with significant margin expansion [15] Market Data and Key Metrics Changes - Infrastructure, the largest end market for CRH, continues to benefit from state and federal funding, with less than 40% of IIJA highway funding deployed to date [13][30] - The residential sector in the U.S. is expected to remain subdued, while repair and remodel activities are resilient [31][32] - Positive pricing momentum is anticipated across markets, supported by disciplined commercial management [32] Company Strategy and Development Direction - CRH is focused on reinvesting in high-growth markets and has allocated approximately $1.7 billion across 19 acquisitions and growth CapEx investments [7][20] - The acquisition of EcoMaterial Technologies is expected to enhance CRH's cementitious growth strategy, significantly increasing its production capacity [23][24] - The company emphasizes a connected portfolio strategy to maximize profitability and operational efficiencies across its business segments [25][29] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the underlying demand across key markets and noted that backlogs are ahead of the prior year [8][40] - The company anticipates continued strong performance in the second half of the year, driven by favorable weather conditions and robust backlogs [40] - Management highlighted the importance of federal and state funding in driving infrastructure demand, with expectations for a supportive legislative environment for future funding [54][56] Other Important Information - CRH has declared a quarterly dividend of $0.37 per share, representing a 6% increase year-over-year, and has repurchased approximately $800 million in shares so far this year [21][22] - The company has a strong pipeline of growth opportunities and plans to maintain a disciplined capital allocation strategy [34][78] Q&A Session Summary Question: Drivers of the full-year guidance increase - Management noted strong Q2 performance with EBITDA up 9% and margins up 70 basis points, despite challenging weather conditions [37] - Infrastructure remains robust, with significant backlogs and positive momentum in July [40] Question: Expectations for U.S. Cement and aggregates - Underlying aggregate volumes were up 5% and pricing up 4% in Q2, with expectations for mid to high single-digit pricing growth for the full year [45][46] Question: Update on federal infrastructure funding - Management indicated a supportive bipartisan environment for the next highway bill, with a focus on surface transportation [54][56] Question: Performance of Adbri and margin expansion drivers - Adbri has performed well since acquisition, and margin expansion is attributed to tight cost control and operational efficiencies [100]

Financial Performance & Capital Allocation - The company returned over $190 million to shareholders in the first half of 2025, including $46 million in 2Q 2025[6] - The company is targeting long-term debt of $1 billion[8, 24] - The board authorized a share repurchase program of $550 million[11] - The company is allocating a minimum of 50% of adjusted free cash flow to share buybacks and potential dividend increases[6, 8, 81] Production & Operations - Second quarter 2025 production reached 190 MBOEPD (thousands of barrels of oil equivalent per day)[5, 19, 20] - Eagle Ford Shale production was 39 MBOEPD, representing 21% of total production[19, 36] - Offshore production was 72 MBOEPD, accounting for 38% of total production[19, 46] - Onshore Canada production was 79 MBOEPD, making up 41% of total production[19, 41] Exploration & Development - The company is progressing with the Lac Da Vang (Golden Camel) project in Vietnam, targeting first oil in 4Q 2026, with an estimated gross recoverable resource of 100 MMBOE (millions of barrels of oil equivalent)[53, 80, 83] - The company plans to spud the Civette well in Côte d'Ivoire in 4Q 2025, with a mean to upward gross resource potential of 440 MMBOE – 1,000 MMBOE[71]

Financial Data and Key Metrics Changes - The company reported total revenues of $10.2 billion for Q2 2025, a 6% increase compared to the prior year, driven by favorable underlying demand and strong contributions from acquisitions [8][9] - Adjusted EBITDA for the quarter was $2.5 billion, reflecting a 9% increase year-over-year, with a margin expansion of 70 basis points [9][17] - The diluted earnings per share increased by 3% compared to the prior year period [9] Business Line Data and Key Metrics Changes - Americas Materials Solutions saw a 24% increase in total revenues and adjusted EBITDA, driven by operational efficiencies and contributions from acquisitions [10] - Essential Materials reported a 4% increase in revenues, supported by increased volumes and positive pricing momentum in Aggregates and Cement [10] - International Solutions experienced a 13% increase in revenue and a 23% increase in adjusted EBITDA, with margin expansion of 170 basis points [14] Market Data and Key Metrics Changes - The infrastructure market remains robust, with less than 40% of the IIJA highway funding deployed, indicating significant future opportunities [12][30] - State transportation budgets for fiscal year 2026 are expected to increase by 6% over the prior year, supporting continued demand [12] - The residential sector in the U.S. is expected to remain subdued, while repair and remodel activities are resilient [30] Company Strategy and Development Direction - The company is focused on reinvesting in high-growth markets and has allocated approximately $1.7 billion across 19 acquisitions and growth CapEx investments [7] - The acquisition of EcoMaterial Technologies for $2.1 billion is expected to enhance the company's cementitious growth strategy and create a unique national distribution network [22][23] - The company emphasizes a connected portfolio that maximizes profitability and operational efficiencies across the construction value chain [25] Management's Comments on Operating Environment and Future Outlook - Management raised the financial guidance for 2025, expecting adjusted EBITDA to be between $7.5 billion and $7.7 billion, representing a 10% growth at the midpoint [8][33] - The company anticipates continued positive momentum in backlogs and underlying demand across key markets [7][30] - Management highlighted the importance of federal and state funding in driving infrastructure demand, with a supportive legislative environment for future funding [30][56] Other Important Information - The company has declared a quarterly dividend of 37¢ per share, a 6% increase from the prior year, and has repurchased approximately $800 million in shares so far this year [19][20] - The company has a strong pipeline of growth opportunities and expects to allocate approximately $35 billion over the next five years for capital investments [34] Q&A Session Summary Question: Drivers of the full year guidance increase - Management noted strong Q2 performance with EBITDA up 9% and margins up 70 basis points despite challenging weather conditions, with robust infrastructure demand and good backlogs contributing to the guidance increase [36][39] Question: Expectations for U.S. Cement and aggregates - Management indicated that underlying aggregate volumes were up 5% and pricing up 4%, with expectations for mid to high single-digit pricing growth for the full year [44][46] Question: Update on federal infrastructure funding and next highway bill - Management confirmed ongoing discussions about the next highway bill, emphasizing a supportive bipartisan environment and the need for a sustainable funding mechanism [52][56] Question: Performance of Adbri and margin expansion drivers - Management reported that Adbri is trading ahead of expectations, with good tailwinds from infrastructure and residential recovery, while margin expansion is attributed to operational excellence and cost control initiatives [99][100]

Q1 FY26 Performance - Revenue reached $249.5 million, a 6.6% decrease compared to the previous year[18, 22] - Organic revenue declined by 6.4% year-over-year, primarily due to Clear Eyes supply constraints[17, 24] - Diluted EPS increased by 5.6% to $0.95 compared to the adjusted prior year[11, 17, 18, 22] - Free cash flow was solid at $78 million[11] Financial Metrics - Gross margin improved to 56.2%[11, 22, 24] - EBITDA remained relatively flat at $79.6 million[17, 18, 22] - EBITDA margin increased to 31.9%[22, 24] - A&M expenses accounted for 14.0% of revenue[22, 24] - G&A expenses represented 11.4% of revenue[22, 24] Strategic Initiatives and Outlook - The company entered into an agreement to acquire Pillar5 Pharma for approximately $100 million[11, 25] - The company repurchased approximately 400,000 shares for $35 million[25] - Full-year revenue is projected to be between $1.1 billion and $1.115 billion[28] - Full-year free cash flow is expected to be $245 million or more[28]

Financial Performance - Q2 2025 revenues on a TCE basis were $92819 thousand[4] - Q2 2025 net income after tax was $56032 thousand[4] - Q2 2025 EPS was $035[4] - Q2 2025 average TCE was $46300 per day for the fleet[5] - Total liquidity as of June 30 2025 was $299 million[8] Balance Sheet - As of June 30 2025 cash was $82660 thousand[6] - As of June 30 2025 total assets were $1430405 thousand[6] - As of June 30 2025 equity was $1088938 thousand[7] - Interest bearing debt to total assets was 141%[9] - Net debt per vessel as of June 30 2025 was $100 million[10] Capital Allocation - A cash dividend of $024 per share was declared[17] - Cash dividend since dividend policy update from Q3 2022 is $275 per share[20] Q3 2025 Outlook - Average term time-charter rate is estimated at $40500 per day[21] - Average spot rate booked to date is $38500 per day with 73% of total spot days booked[21]

Core Viewpoint - Somnigroup International Inc. has declared a third quarter cash dividend of $0.15 per share, payable on September 5, 2025, to shareholders of record as of August 21, 2025 [1] Company Overview - Somnigroup is the world's largest bedding company, focused on enhancing people's lives through better sleep [2] - The company operates in over 100 countries and includes well-known brands such as Tempur-Pedic®, Sealy®, Stearns & Foster®, and Sleepy's® [2] - Somnigroup's global omni-channel platform allows it to meet consumer needs through various shopping experiences, providing tailored sleep solutions [2] Corporate Strategy - The company aims to deliver long-term value for shareholders through prudent capital allocation and investment management [3] - Somnigroup is committed to environmental protection and community responsibility, guided by its core value of Doing the Right Thing [3]

Financial Data and Key Metrics Changes - The company reported a year-over-year revenue growth of 13%, driven by a 14% increase in volume across its portfolio [7][19] - Adjusted EBITDA increased by 14% to $22.7 million compared to $20 million in the prior year [21] - Earnings from continuing operations surged by 198% to $4.4 million, compared to a loss of $4.4 million in the prior year [20] Business Line Data and Key Metrics Changes - The fruit snacks category achieved its twentieth consecutive quarter of double-digit growth, now comprising 20% of total revenue, up from 10% five years ago [12][14] - Beverage and broth unit production increased by 16% and 25% respectively, while fruit snack production rose by 22% year-over-year [13][20] - The foodservice category continued to grow in mid-single digits, with oat products performing particularly well [11] Market Data and Key Metrics Changes - The company noted that all product categories, go-to-market formats, and channels experienced year-over-year growth [10] - The club channel business thrived, up over 25%, as consumers sought quality products at great value [11] - The shelf-stable plant-based beverage category is experiencing high single-digit growth, with expectations for continued acceleration [16] Company Strategy and Development Direction - The company is committed to investing in a new manufacturing line to increase output by approximately 25%, with the new capacity already oversubscribed [15][27] - The strategic focus remains on operational efficiency, gross margin improvements, and capital allocation to drive return on invested capital (ROIC) [6][26] - The long-term growth algorithm targets annual revenue growth of 8% to 10% and adjusted EBITDA growth of 13% to 17% [24] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to execute and create long-term value, despite ongoing consumer and tariff uncertainties [6][15] - The operational improvement plan is on track, with strong momentum across key growth platforms [18][94] - The company is well-positioned to capitalize on consumer trends favoring better-for-you products [17][95] Other Important Information - The company incurred $1.6 million in tariff headwinds on gross profit due to a timing lag in pass-through pricing [7][20] - Cash provided by operating activities for the first two quarters was $17.8 million, compared to $2 million in the prior year [21] - The company repurchased 163,227 common shares in the second quarter, reflecting a commitment to returning excess capital to shareholders [26] Q&A Session Summary Question: Details about the new fruit snacks plan - The new manufacturing line will primarily serve existing customers, with a mix of new opportunities, and is expected to significantly enhance capacity [31][34] Question: Adjusted gross margin progression in the back half of the year - A 90 basis point headwind from tariffs is expected in Q3, but margins should fully recover by Q4 as pricing adjustments are implemented [38][62] Question: Growth among customers in the shelf-stable plant-based beverage category - The company is gaining share primarily through existing customers outperforming their categories, with a mix of new entrants also contributing [52][54] Question: Balancing aseptic capacity for different product lines - Broth production is strategically timed to take advantage of seasonal demand, allowing flexibility in production scheduling [71][74] Question: Investment in new line and capital allocation for 2026 - The new CapEx for fruit snacks will be approximately $25 million, mainly occurring in 2026, with a focus on maintaining a solid balance sheet and leverage ratios [76][78]